#FCI #Masterka #World #Premiere #LacriJet #AAO #Industry #Showcase #Presentation
[ad_1]
Industry Showcase Presented by FCI during AAO Virtual Meeting.
William R. Katowitz, MD presents Masterka® study results and Reynaldo M. Javate, MD, FICS presents Masterka® experience and the upcoming world premiere LacriJet® “pushed” monocanalicular stent.
LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.
Learn more at:
🌐 https://fciworldwide.com/products/lacrijet
🇺🇸 Coming soon! Pending FDA approval
Masterka® is FCI innovative solution for the treatment of congenital nasolacrimal duct obstruction resistant to probing. Unlike the traditional “pulled” technique, Masterka® has no metallic probe or suture attached to it and is therefore not pulled out of the nose.
Learn more at:
🌐 https://fciworldwide.com/products/masterka
🇺🇸 https://fci-ophthalmics.com/products/masterka
Follow us on LinkedIn:
🖥️ https://www.linkedin.com/company/fci-ophthalmics/
[ad_2]
